Loading…
Loading…
TOKE (Cambria Cannabis ETF) is no longer actively trading.
This usually means the fund has been liquidated, merged into another product, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Cambria Cannabis ETF is a global, all-cap portfolio that has exposure to the broad cannabis industry. TOKE will target approximately 20 to 50 of the top cannabis companies around the world. Why TOKE?
Is TOKE's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
Cannabis stocks have seen renewed investor interest as federal policy momentum improves. The most important recent development was the placement of FDA-approved marijuana products and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act.
MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Cambria Investment Management announced the scheduled liquidation of the Cambria Cannabis ETF (TOKE).
Cannabis ETF spent the first half of the year in the performance doldrums. But they have rallied of late on news that the Trump administration is open to reclassifying marijuana as a less dangerous drug.
One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. We can see that with more than 88% of Americans wanting to see legalization.
On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tickers, among other topics. Afterward, Bancreek CEO and CIO Andrew Skatoff spoke with Geraci about his investment philosophy.